The increasing frequency of bacterial resistance to antibiotics is alarming. Researchers from the Albert Einstein College of Medicine of Yeshiva University believe they may have found a solution to this seemingly losing battle. Professor Vern L. Schramm and team have developed antibiotic compounds that do not lead to microbial resistance over time.
Administered antibiotics initially work extremely well, killing more than 99.9% of the microbes they target. However, microbes have a high rate of mutation and because antibiotics are initially designed for a single specific target, they are unable to kill 100% of microbes during an infection. The surviving microbes that have successfully avoided antibiotics continue to replicate and spread, leading to new antibiotic resistant strains over time.
Dr. Schramm hypothesized that antibiotics do not necessarily have to kill the microbe itself, but rather, disrupt their infectious nature. In other words, if the microbe survives but does not replicate, then resistance to antibiotics will not occur.
In the Nature of Chemical Biology study, test microbes Vibrio cholerae, which causes cholera, and E. coli strain 0157:H7, the notorious food contaminant responsible for ~110,000 illnesses each year in the U.S. were used. The aim of the research study was to disrupt the infectious microbes' ability to communicate with each other.
The process by which bacteria communicate is called "quorum sensing." In quorum sensing, signaling molecules known as "autoinducers" are detected between bacteria. These autoinducers regulate expression of bacterial genes, including genes associated with virulence. Previous studies have shown that bacterial strains defective in quorum sensing are less infectious.
The bacterial enzyme "MTAN" is directly involved in synthesizing autoinducers and is crucial in catalyzing quorum sensing. The team's aim was to inhibit MTAN by designing a substrate to which the enzyme would preferentially bind to as opposed to its human host substrate.
In order to design an analog of MTAN's natural substrate, the Schramm lab obtained a picture of the enzyme's structure during its brief transitional state period (one-tenth of one trillionth of a second) in which the enzyme converts its substrate into a different chemical.
With knowledge of the enzyme's transitional structure, Dr. Schramm and his colleagues constructed and tested three MTAN transition state analogs. All three compounds developed were highly successful in disrupting the quorum sensing pathway in both V. cholerae and E. coli 0157:H7. Not only did MTAN preferentially bind to Schramm's analogs, but in fact, the analogs permanently inhibited the enzyme from initiating quorum sensing.
To test if the microbes would develop resistance over time, the researchers tested the analogs on 26 successive generations of both bacterial species. All 26 generations were as sensitive to the antibiotics as the first generation was.
"In our lab, we call these agents everlasting antibiotics," said Dr. Schramm.
Dr. Schramm also points out that many aggressive bacterial pathogens express MTAN and therefore would probably also be susceptible to these inhibiting analogs including: S. pneumoniae, Klebsiella pneumoniae, N. meningitides, and Staphylococcus aureus.
To date, Schramm's research team has developed more than 20 highly effective MTAN inhibitors, all of which are expected to be safe for human usage since MTAN is a bacterial enzyme and blocking it would have no effect on human metabolism.
The study, "Transition State Analogs of 5'-Methylthioadenosine Nucleosidase Disrupt Quorum Sensing" was published in the March 8, 2009 online edition of Nature Chemical Biology.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Researchers Created A Laser Bullet To See What It Would Look Like - And Here It Is
- The Strange Organic Molecules In Titan's Atmosphere
- How Gut Bacteria Ensure A Healthy Brain – and Could Play A Role In Treating Depression
- The Quote Of The Week - Shocked And Disappointed
- Will Holding Thermal Printer Paper Really Send Your BPA Levels Soaring?
- As The Weather Changes, So Do Beliefs About Climate Change
- Moderate Pot Use By Adolescents Doesn't Hurt IQ
- "BTW Nury, I don't think you will find that many, if any atheists advocate barbaric and extremely..."
- "I cleaned up the code to better exclude partial years...."
- "I admit: I have (only) glanced through two of the three links you have given in your reply (not..."
- "So the people most qualified to help are working for free at night? I doubt that. Anyway, you objected..."
- US Ebola hysteria and money pit highlight lack of resources to confront diseases that kill far more people
- Addiction can be measured by epigenetics
- Coffee grounds turned biofuel can heat your home
- Bill and Melinda Gates on GMOs: ‘Poor farmers should not be denied choice of life-saving tools’
- Why do foodies love organics? Because they taste like McDonald’s!
- GMO milk? An enviros dream innovation that most enviros oppose
- Sunshine may slow weight gain and diabetes onset, study suggests
- Mother's gestational diabetes linked to daughters being overweight later
- An over-the-scope clipping device for endoscopic management of gastrointestinal defects is safe and effective
- Bodies at sea: Ocean oxygen levels may impact scavenger response
- Screening questions fail to identify teens at risk for hearing loss